Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate | Zendy

Massimo Campieri | Zendy; Paolo Gionchetti | Zendy; Andrea Belluzzi | Zendy; M. Tampieri | Zendy; C. Brignola | Zendy; M. Ferretti | Zendy; M. Miglioli | Zendy; Barbara Leggett | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate

Author(s) -

Massimo Campieri,

Paolo Gionchetti,

Andrea Belluzzi,

M. Tampieri,

C. Brignola,

M. Ferretti,

M. Miglioli,

Barbara Leggett

Publication year - 1990

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/1990/164896

Subject(s) - ulcerative colitis , medicine , aminosalicylic acid , enema , gastroenterology , colitis , disease

5-Aminosalicylic acid (5-ASA) enemas constitute a first-linetherapy for patients with mild to moderate attacks of ulcerative colitis. To date,based on the results of different studies, 5-ASA enemas appear to be satisfactoryin at least two-thirds of patients treated. Beclomethasone is one of the newcorticosteroids which appear to have minimal systemic effects. The authors haveassessed the efficacy of a four week course of 3 mg beclomethasone enemascompared to 2 g 5-ASA enemas in patients with ulcerative colitis. Preliminaryanalysis would suggest that both therapies are effective in more than 50% of cases

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research